Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159

Archives of Pharmacal Research

Volumn 25, Issue 6, 2002, Pages 873-878

  Doh, Hyounmie ^a   Chang, Yell Shin ^a   Son, Miwon ^a   Jun, Il Ko ^a   Yoo, Moohi ^a   Soon, Hoe Kim ^a   Won, Bae Kim ^a  

^a Dong A Pharmaceutical Company   (South Korea)

Author keywords

cGMP; DA 8159; Intracavernous pressure (ICP); PDE isozymes; Phosphodiesterase 5 inhibitor; Rabbit corpus cavernosum

Indexed keywords

CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; ISOENZYME; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PYRIMIDINE DERIVATIVE; UDENAFIL;

ANIMAL; ARTICLE; CATTLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FROG; HUMAN; IN VITRO STUDY; ISOLATION AND PURIFICATION; MALE; METABOLISM; PENIS; PENIS ERECTION; PHYSIOLOGY; RABBIT; SMOOTH MUSCLE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CATTLE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOENZYMES; MALE; MUSCLE, SMOOTH; PENILE ERECTION; PENIS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PYRIMIDINES; RABBITS; RANA CATESBEIANA;

EID: 0038003861     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977007     Document Type: Article

References (26)

1. Andersson, K-E. and Wagner, G., Physiology of penile erection. Physiol. Rev., 75, 191- 236 (1995).
2. Artemyev, O. A., Arshavsky, V. Y. and Cote, R. H., Photoreceptor phosphodiesterase: interaction of inhibitory gamma subunit and cyclic GMP with specific binding sites on catalytic subunits. Methods, 14, 93-104 (1998).
3. Azadzoi, K. M. and De Tajeda, I. S., Hypercholestrolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J. Urol., 146, 238-240 (1991).
4. Ballard, S. T., Gingell, C. J.,Tang, K., Turner, L. A., Price, M. E. and Naylor A. M., Effects of Sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J. Urol., 159, 2164-2171 (1998).
5. Beavo, J. A., Cyclic nucleotide phophodiesterase: functional implications of multiple isoform. Physiol. Rev., 75, 725-748 (1995).
6. Burentt, A. L., Role of nitric oxide in the physiology of erection. Biol. Reprod., 52, 485-489 (1995).
7. Burnett, A. L., Lowenstein, C. J., Bredt, D. S., Chang, T. S. K. and Snyder, S. H., Nitric oxide: a physiologic mediator of penile erection. Scinece, 257, 401-403 (1992).
8. Corbin, J. D. and Francis, S. H., Cyclic GMP phosphodiesterase-5: target of sildenafil. J. Biol. Chem., 274, 13729-13732 (1999).
9. Corbin, J. D., Turko, I. V., Beasley, A. and Francis, S. H., Phosphorylation of phosphodiesterase-5 by cyclic nucleotidedependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem., 267, 2760-2767 (2000).
10. De Tajeda, I. S., Goldstein I., Adazoi, K., Krane, R. J. and Cohen, R. A., Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med., 320, 1025-1030 (1989).
11. Dishy, V., Sofowora, G., Harris, P. A., Kandcer, M., Zhan, F., Wood, A. J. and Stein, C. M., The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Clin. Pharmacol. Ther., 70(3), 270-279 (2001).
12. Dousa, T. P., Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int., 55, 2962 (1999).
13. Ekholm, D., Belfrage, P., Manganiello, V. and Degerman, E., Protein kinase A-dependent activation of PDE4 (cAMP-specific nucleotide phosphodiesterase) in cultured bovine vascular smooth muscle cells. Biochim. Biophys. Acta, 1356, 6470 (1997).
14. Finberg, J. P. M., Levy, S. and Vardi, Y., Inhibition of nerve stimulation-induced vasodilation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthetase. Br. J. Pharmacol., 108, 1038-1042 (1993).
15. Fink, T. L., Francis, S. H., Beasley, A., Grimes, K. A. and Corbin, J. D., Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). J. Biol. Chem., 274, 34613-34620 (1999).
16. Freelish, M. and Noack, E., Correlation between nitric acid formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol., 139, 19-30 (1987).
17. Gillespie, P. G., and Beavo J. A., Inhibition and stimulation of photoreceptor by dipyridamol and M&B. Mol. Pharm., 36, 773-781 (1989).
18. Hidaka, H. and Asano, T., Human blood platelet 3′: 5′-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase. Biochim. Biophys. Acta, 429, 485-497 (1976).
19. Hidaka, H. and Shibuya, M., A new assay of cyclic nucleotide phosphodiesterase; its application to human serum. Biochem. Med., 10, 301-311 (1974).
20. Hurley, J. B. and Stryer, L., Purification and characterization of the gamma regulatory subunit of the cyclic GMP phosphodiesterase from retinal rod outer segments. J. Biol. Chemistry, 257, 11094-11099 (1982).
21. Hurwitz, R. L., Bunt-Milam, A. H., Chang, M. L. and Beavo, J. A., cGMP phosphodiesterase in rod and cone outer segments of the retina. J. Mol. Biol., 260, 568-573 (1985).
22. Jeremy, J. Y., Ballard, S. A., Naylor, A. M., Miller, M. A. W. and Angelini, G. D., Effects of Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic Amp levels in the rabbit corpus cavernosum in vitro. Br. J. Urol., 79, 958-963 (1997).
23. Lim, J., Pahlke, G. and Conti, M., Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation: identification and function of an inhibitory domain. J. Biol. Chem., 274, 19677-19685 (1999).
24. Lue, T. F., Hemodynamics of erection in the monkey. J. Urol., 130, 1237-1241 (1983).
25. Trigo-Rocha, F., Hsu, G. L., Donatucci, C. F. and Lue, T. F., The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic, neurotranasmission in canine penile erection. J. Urol., 149, 872-877 (1993).
26. Wang, J. H., Teo, T. S., Ho, H. C., and Stevens, F. S., Bovine heart protein activator of cyclic nucleotide phosphodiesterase. Adv. in Cyclic Nucleotide Res., 5., 179-194 (1975).